Who Paid My Doc
Tzield
Biological Endocrine & Metabolic Diseases
NDC 73650-316-01
General payments
$9,530,345
Research payments
$3,165,947
Through program year 2025, $9,530,345 in general payments and $3,165,947 in research payments were reported against Tzield (Endocrine & Metabolic Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,631,804 | 33,289 |
| 2025 | Research | $342,007 | 91 |
| 2024 | General | $3,619,761 | 27,698 |
| 2024 | Research | $2,164,820 | 203 |
| 2023 | General | $1,275,883 | 7,569 |
| 2023 | Research | $659,120 | 66 |
| 2022 | General | $2,897 | 52 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 141 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
68,608 general · 360 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.